Taken together, our present study provides strong evidence that melatonin modulates MI-associated NLRP3 inflammasome-mediated cardiac pyroptosis by affecting the TLR4/NF-κB signaling pathway, suggesting its utility in the treatment of MI. Here, TLR4 is linked to myocardial infarction.